MA27998A1 - Nouvelle formulation - Google Patents
Nouvelle formulationInfo
- Publication number
- MA27998A1 MA27998A1 MA28819A MA28819A MA27998A1 MA 27998 A1 MA27998 A1 MA 27998A1 MA 28819 A MA28819 A MA 28819A MA 28819 A MA28819 A MA 28819A MA 27998 A1 MA27998 A1 MA 27998A1
- Authority
- MA
- Morocco
- Prior art keywords
- new formulation
- ropinirole
- rls
- diseases
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Formulation nouvelle de ropinirole La présente invention concerne des formulations nouvelles de ropinirole pour administration orale, et leur utilisation dans le traitement de maladies qui peuvent empêcher ou perturber le sommeil, en particulier du syndrome des jambes sans repos (RLS).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0319874.4A GB0319874D0 (en) | 2003-08-22 | 2003-08-22 | Novel formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27998A1 true MA27998A1 (fr) | 2006-07-03 |
Family
ID=28460214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28819A MA27998A1 (fr) | 2003-08-22 | 2006-02-17 | Nouvelle formulation |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070059365A1 (fr) |
EP (1) | EP1656118A2 (fr) |
JP (1) | JP2007503414A (fr) |
KR (1) | KR20060120596A (fr) |
CN (1) | CN1838945A (fr) |
AR (1) | AR045289A1 (fr) |
AU (1) | AU2004266072A1 (fr) |
BR (1) | BRPI0413632A (fr) |
CA (1) | CA2536414A1 (fr) |
GB (1) | GB0319874D0 (fr) |
IL (1) | IL173440A0 (fr) |
IS (1) | IS8352A (fr) |
MA (1) | MA27998A1 (fr) |
MX (1) | MXPA06002023A (fr) |
NO (1) | NO20061291L (fr) |
RU (1) | RU2006109010A (fr) |
TW (1) | TW200517107A (fr) |
WO (1) | WO2005018605A2 (fr) |
ZA (1) | ZA200600719B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007073325A1 (fr) | 2005-12-20 | 2007-06-28 | Cereuscience Ab | Procédé et composition servant à traiter et à diagnostiquer le syndrome des jambes sans repos |
WO2008085484A2 (fr) * | 2006-12-28 | 2008-07-17 | Jacobus Pharmaceutical Company, Inc. | Procédé de traitement de l'affection abdominale inflammatoire |
EP2022496A1 (fr) * | 2007-07-16 | 2009-02-11 | Ranbaxy Laboratories Limited | Compositions stables de ropinirole |
EP2175840A2 (fr) * | 2007-08-14 | 2010-04-21 | Dr. Reddy's Laboratories, Ltd. | Compositions pharmaceutiques comprenant du ropinirole |
US20090076124A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched ropinirole |
WO2009078034A2 (fr) * | 2007-11-26 | 2009-06-25 | Rubicon Research Private Limited | Comprimés de chlorhydrate de ropinirole se désintégrant par voie orale |
CN101574341B (zh) * | 2008-05-05 | 2012-12-19 | 北京德众万全医药科技有限公司 | 一种罗匹尼罗的口服固体药物组合物 |
SI22849A (sl) * | 2008-08-01 | 2010-02-26 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Ropinirolni pripravek |
WO2010015911A1 (fr) * | 2008-08-06 | 2010-02-11 | Torrent Pharmaceuticals Limited | Compositions pharmaceutiques à libération prolongée de ropinirole et leur procédé de préparation |
WO2010023693A2 (fr) * | 2008-09-01 | 2010-03-04 | Lupin Limited | Nouvelles compositions de ropinirole à libération contrôlée |
EP2452677A1 (fr) | 2008-09-29 | 2012-05-16 | Wockhardt Limited | Forme posologique à libération prolongée de ropinirole |
WO2010044108A2 (fr) | 2008-10-17 | 2010-04-22 | Rubicon Research Private Limited | Formulations à libération contrôlée de ropinirole |
BRPI1007945C8 (pt) * | 2009-02-13 | 2021-05-25 | Romark Laboratories Lc | formulação farmacêutica de liberação controlada de nitazoxanida, tizoxanida ou uma combinação dos mesmos, e, comprimido de bicamada para administração oral |
WO2011032416A1 (fr) * | 2009-09-19 | 2011-03-24 | 浙江华海药业股份有限公司 | Composition pharmaceutique contenant un agoniste des récepteurs de la dopamine |
KR101068476B1 (ko) * | 2009-12-29 | 2011-09-28 | 환인제약 주식회사 | 로피니롤 경구 투여용 서방성 제제 |
GR1007629B (el) * | 2011-07-13 | 2012-06-29 | Φαρματεν Αβεε, | Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης |
US20140377347A1 (en) * | 2012-01-23 | 2014-12-25 | Ranbaxy Laboratories Limited | In-situ multilayered tablet technology |
ITFI20130189A1 (it) * | 2013-08-05 | 2015-02-06 | Valpharma Internat S P A | Una composizione farmaceutica contenente ropinirolo hcl somministrabile per via orale e metodo di produzione. |
US9463889B2 (en) * | 2013-10-25 | 2016-10-11 | Medtronic, Inc. | Prefilled reservoir apparatus for ambulatory infusion device |
CN104188931B (zh) * | 2014-08-25 | 2017-06-16 | 泰州越洋医药开发有限公司 | 一种盐酸罗匹尼罗固体口服控释片剂及其制备方法 |
CN104473893A (zh) * | 2014-11-21 | 2015-04-01 | 哈尔滨圣吉药业股份有限公司 | 一种盐酸罗匹尼罗缓释片及其制备方法 |
AU2016278846B2 (en) | 2015-06-19 | 2021-08-05 | Biotie Therapies, Inc. | Controlled-release tozadenant formulations |
CN114727965B (zh) * | 2019-12-23 | 2023-12-12 | 江苏恒瑞医药股份有限公司 | 一种jak激酶抑制剂药物组合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
IT1237904B (it) * | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
IT1265240B1 (it) * | 1993-11-30 | 1996-10-31 | Ekita Investments Nv | Compressa farmaceutica a rilascio controllato, di forma lenticolare |
US20010029262A1 (en) * | 1998-06-29 | 2001-10-11 | Sethi Kapil Dev | Method of treatment or prophylaxis |
AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
GB0125088D0 (en) * | 2001-10-18 | 2001-12-12 | Smithkline Beecham Cork Ltd | New use |
ES2589077T3 (es) * | 2002-06-25 | 2016-11-10 | Acrux Dds Pty Ltd | Control de la tasa de administración transdérmica usando composiciones farmacéuticas amorfas |
-
2003
- 2003-08-22 GB GBGB0319874.4A patent/GB0319874D0/en not_active Ceased
-
2004
- 2004-08-19 WO PCT/EP2004/009356 patent/WO2005018605A2/fr active Application Filing
- 2004-08-19 MX MXPA06002023A patent/MXPA06002023A/es not_active Application Discontinuation
- 2004-08-19 BR BRPI0413632-2A patent/BRPI0413632A/pt not_active IP Right Cessation
- 2004-08-19 US US10/569,398 patent/US20070059365A1/en not_active Abandoned
- 2004-08-19 KR KR1020067003501A patent/KR20060120596A/ko not_active Application Discontinuation
- 2004-08-19 CN CNA2004800241337A patent/CN1838945A/zh active Pending
- 2004-08-19 CA CA002536414A patent/CA2536414A1/fr not_active Abandoned
- 2004-08-19 JP JP2006524307A patent/JP2007503414A/ja active Pending
- 2004-08-19 EP EP04764339A patent/EP1656118A2/fr not_active Withdrawn
- 2004-08-19 RU RU2006109010/15A patent/RU2006109010A/ru not_active Application Discontinuation
- 2004-08-19 AU AU2004266072A patent/AU2004266072A1/en not_active Abandoned
- 2004-08-20 AR ARP040102989A patent/AR045289A1/es not_active Application Discontinuation
- 2004-08-20 TW TW093125047A patent/TW200517107A/zh unknown
-
2006
- 2006-01-25 ZA ZA200600719A patent/ZA200600719B/xx unknown
- 2006-01-30 IL IL173440A patent/IL173440A0/en unknown
- 2006-02-17 MA MA28819A patent/MA27998A1/fr unknown
- 2006-03-14 IS IS8352A patent/IS8352A/is unknown
- 2006-03-21 NO NO20061291A patent/NO20061291L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1656118A2 (fr) | 2006-05-17 |
IS8352A (is) | 2006-03-14 |
AU2004266072A1 (en) | 2005-03-03 |
US20070059365A1 (en) | 2007-03-15 |
KR20060120596A (ko) | 2006-11-27 |
JP2007503414A (ja) | 2007-02-22 |
CA2536414A1 (fr) | 2005-03-03 |
IL173440A0 (en) | 2006-06-11 |
MXPA06002023A (es) | 2006-05-17 |
ZA200600719B (en) | 2007-03-28 |
CN1838945A (zh) | 2006-09-27 |
NO20061291L (no) | 2006-05-16 |
GB0319874D0 (en) | 2003-09-24 |
RU2006109010A (ru) | 2006-08-10 |
BRPI0413632A (pt) | 2006-10-17 |
AR045289A1 (es) | 2005-10-19 |
TW200517107A (en) | 2005-06-01 |
WO2005018605A2 (fr) | 2005-03-03 |
WO2005018605A3 (fr) | 2005-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27998A1 (fr) | Nouvelle formulation | |
ATE491436T1 (de) | Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen | |
PT1347971E (pt) | Inibidores tiazolilicos de tirosina-cinases da familia tec | |
TR200103233T2 (tr) | Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri. | |
BRPI0407583A (pt) | solução oftálmica lìmpida e estável | |
PL352318A1 (en) | Fish serine proteinases, and pharmaceutical and cosmetic use of same | |
EA200100872A1 (ru) | Композиция валдекоксиба | |
TR200200065T2 (tr) | Dış salgılama bozukluklarının tedavisi için terkip | |
YU49202A (sh) | Benzazolski derivati i njihova upotreba kao modulatora jnk | |
TW200510328A (en) | 5-membered heterocycle-based p38 kinase inhibitors | |
PL375621A1 (en) | Pharmaceutical compositions comprising flavonoids and menthol | |
TNSN00010A1 (fr) | DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE. | |
ATE350364T1 (de) | Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen | |
MA27929A1 (fr) | Utilisation de calcitonine pour le traitement de l'osteoarthrite | |
JO2356B1 (en) | N-by-phenyl derivatives (methyl substituted) amino cycloalkan carboxamide | |
EE05357B1 (et) | Tablett, mis sisaldab vhemalt kahte eristatavat segmenti, ning selle kasutamine | |
DE60303441D1 (en) | N-biphenylmethylaminocycloalkancarboxamid-derivative | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
ATE422201T1 (de) | 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen | |
DK1228097T3 (da) | Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge | |
DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
SE0001916D0 (sv) | Novel formulation | |
DE60208701D1 (de) | Verwendung von cetrorelix zur behandlung vom jakob-creutzfeldt-syndrom | |
DK1273301T3 (da) | Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration | |
IT1317905B1 (it) | Varianti di allergeni ns-ltps, loro usi e composizioni che lecomprendono. |